PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30353992-3	2018	HYPOTHESIS/OBJECTIVE: To assess if changes in plasma cytokeratin 18 (CK18) concentration, measured in dogs being treated with toceranib phosphate, can predict the onset of GI toxicosis.	toceranib phosphate	126-145	keratin 18	Canis lupus familiaris	53-67	
30353992-3	2018	HYPOTHESIS/OBJECTIVE: To assess if changes in plasma cytokeratin 18 (CK18) concentration, measured in dogs being treated with toceranib phosphate, can predict the onset of GI toxicosis.	toceranib phosphate	126-145	keratin 18	Canis lupus familiaris	69-73	
30353992-4	2018	We hypothesize that an increase in CK18 concentrations will be detected before the development of GI toxicosis in dogs treated with toceranib phosphate.	toceranib phosphate	132-151	keratin 18	Canis lupus familiaris	35-39